Neural Regeneration Research ›› 2017, Vol. 12 ›› Issue (6): 914-915.doi: 10.4103/1673-5374.208571

Previous Articles     Next Articles

Heparan sulfate proteoglycans and heparanases in Alzheimer’s disease: current outlook and potential therapeutic targets

Laura Lorente-Gea1, Beatriz García2, 3, Carla Martín2, 3, Luis M. Quirós2, 3, Iván Fernández-Vega1, 3, 4, 5   

  1. 1 Department of Pathology, Hospital Universitario de Araba-Txagorritxu, Vitoria-Gasteiz, Spain; 2 Department of Functional Biology, University of Oviedo, Oviedo, Spain; 3 Instituto Universitario Fernández-Vega, Oviedo, Spain; 4 Department of Pathology, Hospital Universitario Central de Asturias, Oviedo, Spain; 5 BiobancoVasco para la Investigación (O+eHun), Brain Bank, Hospital Universitario Araba, Vitoria-Gasteiz, Spain
  • Received:2017-06-12 Online:2017-06-15 Published:2017-06-15
  • Contact: Iván Fernández-Vega, M.D., Ph.D., ivan_fernandez_vega@hotmail.com.